BREAKING

Insight Enterprises Jumps 7.4% Amid Broad Rally 21 minutes ago The Boston Beer Company Shares Drop 5.5% 2 hours ago Avnet Jumps 7.3% Amid Sector-Wide Rally 2 hours ago Arrow Electronics Jumps 6.8% Amid Sector-Wide Rally 3 hours ago UiPath, Inc. Jumps 6.8% Amid Sector-Wide Selling 3 hours ago Teradata Corporation Jumps 6.6% Amid Sector-Wide Selling 4 hours ago Patterson-UTI Energy, Inc. Shares Jumping 5.6% 4 hours ago AeroVironment, Inc. Jumps 5.2% Amid Sector-Wide Selling 4 hours ago FormFactor, Inc. Shares Jumping 6.3% 4 hours ago Synopsys, Inc. Jumps 5.0% Amid Sector-Wide Selling 4 hours ago Insight Enterprises Jumps 7.4% Amid Broad Rally 21 minutes ago The Boston Beer Company Shares Drop 5.5% 2 hours ago Avnet Jumps 7.3% Amid Sector-Wide Rally 2 hours ago Arrow Electronics Jumps 6.8% Amid Sector-Wide Rally 3 hours ago UiPath, Inc. Jumps 6.8% Amid Sector-Wide Selling 3 hours ago Teradata Corporation Jumps 6.6% Amid Sector-Wide Selling 4 hours ago Patterson-UTI Energy, Inc. Shares Jumping 5.6% 4 hours ago AeroVironment, Inc. Jumps 5.2% Amid Sector-Wide Selling 4 hours ago FormFactor, Inc. Shares Jumping 6.3% 4 hours ago Synopsys, Inc. Jumps 5.0% Amid Sector-Wide Selling 4 hours ago

ADVERTISEMENT

BM

BMY

All BMY Content

46 articles, transcripts, and reports

salesforce

Breaking News

BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit

BioNTech posts wider-than-expected Q4 loss of $0.33/share as COVID vaccine revenue plunges 24% year-over-year; founders to exit for new mRNA venture.

March 11, 20263 min read

Bristol-Myers Squibb Company (BMY) Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma

Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release

March 9, 20261 min read

Bristol-Myers Squibb Company (BMY) U.S. FDA Approves Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis

Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release

March 7, 20261 min read

Bristol-Myers Squibb Company (BMY) Dividend Update

Bristol-Myers Squibb Company (NYSE: BMY) Q2 2026 Dividend Update

March 2, 20261 min read

ADVERTISEMENT

Bristol-Myers Squibb Company (BMY) SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer

Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release

February 26, 20261 min read

Bristol-Myers Squibb Company (BMY) Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity

Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release

February 24, 20261 min read

Bristol-Myers Squibb Company (BMY) TD Cowen 46th Annual Health Care Conference

Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Corporate Conference

February 23, 20261 min read

Bristol-Myers Squibb Company (BMY) nnounces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (α)-Thalassemia

Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release

February 23, 20261 min read

ADVERTISEMENT

Bristol-Myers Squibb Company (BMY) U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s New Drug Application for Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma

Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release

February 17, 20261 min read

Bristol-Myers Squibb Company (BMY) Sec Form 10K

Bristol-Myers Squibb Company (NYSE: BMY) Sec Form 10K

February 12, 20261 min read